Page last updated: 2024-08-18

pyrroles and Palsy

pyrroles has been researched along with Palsy in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's1 (14.29)18.2507
2000's3 (42.86)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, Y; Shao, X; Xie, K; Yin, H; Zeng, T; Zhang, C; Zhao, X1
Bravo, M; Hur, EM; Mitchell, DJ; Patarroyo, JC; Radosevich, JL; Ruiz, PJ; Sobel, RA; Steinman, L; Stüve, O; Youssef, S; Zamvil, SS1
Aktas, O; Brocke, S; Dorr, J; Endres, M; Nitsch, R; Prozorovski, T; Sallach, S; Seeger, B; Smorodchenko, A; Waiczies, S; Zipp, F1
THIELE, S; WITH, TK1
Barbosa, E; Christie, DK; Pannu, R; Singh, AK; Singh, I1
Erwin, WD; Gullikson, GW; Loeffler, R; Virina, MA1
Grafe, P; Lehmann-Horn, F; Spuler, A1

Other Studies

7 other study(ies) available for pyrroles and Palsy

ArticleYear
Biological exposure indices of pyrrole adducts in serum and urine for hazard assessment of n-hexane exposure.
    PloS one, 2014, Volume: 9, Issue:1

    Topics: Adult; Animals; Biomarkers; Body Weight; Female; Gait; Hexanes; Humans; Male; Middle Aged; Occupational Exposure; Paralysis; Presynaptic Terminals; Pyrroles; Rats; Time Factors; Young Adult

2014
The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
    Nature, 2002, Nov-07, Volume: 420, Issue:6911

    Topics: Adoptive Transfer; Amino Acid Sequence; Animals; Antigen-Presenting Cells; Atorvastatin; Cell Division; Central Nervous System Diseases; Cytokines; DNA-Binding Proteins; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Expression; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Macrophages; Mice; Microglia; Molecular Sequence Data; Multiple Sclerosis; Nuclear Proteins; Paralysis; Phosphorylation; Pyrroles; RNA, Messenger; STAT4 Transcription Factor; STAT6 Transcription Factor; Th2 Cells; Trans-Activators

2002
Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin.
    The Journal of experimental medicine, 2003, Mar-17, Volume: 197, Issue:6

    Topics: Animals; Apoptosis; Atorvastatin; CD4-Positive T-Lymphocytes; Cell Cycle; Cell Division; Cell Line; Encephalomyelitis, Autoimmune, Experimental; Female; Genes, MHC Class II; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Mice; Mice, Inbred Strains; Myelin Proteolipid Protein; Paralysis; Peptide Fragments; Pyrroles; Recurrence; Spinal Cord; Th1 Cells

2003
ACUTE INTERMITTENT PORPHYRIA; DIAGNOSIS FOUR YEARS POST MORTEM BY CHEMICAL STUDIES IN RELATIVES.
    Scandinavian journal of clinical and laboratory investigation, 1964, Volume: 16

    Topics: Diagnosis, Differential; Genetics, Medical; Humans; Levulinic Acids; Necrosis; Pancreas; Paralysis; Porphyria, Acute Intermittent; Porphyrias; Porphyrins; Pyrroles; Urine

1964
Post-trauma Lipitor treatment prevents endothelial dysfunction, facilitates neuroprotection, and promotes locomotor recovery following spinal cord injury.
    Journal of neurochemistry, 2007, Volume: 101, Issue:1

    Topics: Animals; Atorvastatin; Blood-Brain Barrier; Chemotaxis, Leukocyte; Cytokines; Down-Regulation; Endothelial Cells; Female; Gait Disorders, Neurologic; Heptanoic Acids; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Neuroprotective Agents; Paralysis; Pyrroles; Rats; Rats, Sprague-Dawley; Recovery of Function; Regional Blood Flow; rhoA GTP-Binding Protein; Spinal Cord; Spinal Cord Injuries; Terpenes; Treatment Outcome

2007
Alpha 2-adrenergic model of gastroparesis: validation with renzapride, a stimulator of motility.
    The American journal of physiology, 1991, Volume: 261, Issue:3 Pt 1

    Topics: Adrenergic alpha-Agonists; Animals; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cresols; Disease Models, Animal; Dogs; Duodenum; Eating; Gastric Emptying; Gastrointestinal Motility; Muscle, Smooth; Paralysis; Pyrroles; Receptors, Adrenergic, alpha; Serotonin Antagonists; Stomach Diseases; Technetium Tc 99m Sulfur Colloid

1991
Cromakalim (BRL 34915) restores in vitro the membrane potential of depolarized human skeletal muscle fibres.
    Naunyn-Schmiedeberg's archives of pharmacology, 1989, Volume: 339, Issue:3

    Topics: Barium; Benzopyrans; Cromakalim; Humans; Hyperkalemia; In Vitro Techniques; Membrane Potentials; Muscles; Paralysis; Pyrroles; Tolbutamide

1989